Care leavers across the UK will no longer be required to pay application fees for university or college, Ucas has confirmed. It is a significant step aimed at bridging the persistent gap in higher ...

Terry Lane is a writer for Investopedia with 25 years of experience in journalism and communications. He covers personal finance, Congress, government regulations, and economics. SDI Productions / ...

LE BOURGET—The French military and Dassault Aviation are working to have a new, large combat drone ready early next decade for the service entry of the latest Rafale F5 fighter. The uncrewed combat ...

Stocks performed poorly in 2022. The Nasdaq and Russell 2000 saw the biggest declines. The Dow held up reasonably well compared to its peers. The stock market couldn't resist giving investors a ...

If you’re applying to college this fall, you may have heard the term “comprehensive review.” It’s an approach that many schools, including the University of California, use to make admissions ...

In today’s competitive job market, having a thorough understanding of the job application process is essential for standing out from the crowd and securing employment opportunities. By familiarizing ...

National health expenditures are projected to grow 5.4 percent, on average, over the course of 2022–31 and to account for roughly 20 percent of the economy by the end of that period. The insured share ...

For Transparency International, 2022 was a year of creating vital, lasting change around the world. We are a global movement with more than 100 independent national chapters and partners working ...

The Chiefs finished the final chapter of the 2022 NFL season, but we all know there's never a dull stretch on the NFL calendar. Before the NFL combine is the appropriate time to take in everything we ...

For a time during the fourth quarter, it looked like help was on the way for investors after a brutal first three quarters of the year. But by the end of 2022, relief over a potential slowing in ...

Last year the FDA’s Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. This is a drop from the highs of the past 5 years, and brings the rolling 5-year average down to 49 drugs ...